Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Org Chem ; 85(15): 9491-9502, 2020 Aug 07.
Article in English | MEDLINE | ID: mdl-32692168

ABSTRACT

The functionalization of indoles in the carbocyclic ring has been achieved via organocatalytic enantioselective Friedel-Crafts benzhydrylation of hydroxyindoles with in situ generated ortho-quinomethanes in oil-water biphases, allowing an efficient access to varied diarylindolylmethanes with a wide substrate scope. The high yields, excellent stereoselectivities, mild conditions, low catalyst loading, and easy scalability also demonstrated the interest of this novel methodology.

2.
Org Biomol Chem ; 18(13): 2398-2404, 2020 04 01.
Article in English | MEDLINE | ID: mdl-32191253

ABSTRACT

A highly regioselective and enantioselective N-alkylation of isoxazol-5-ones with para-quinone methides promoted by bi-functional squaramide catalysts was developed. This unexpected asymmetric N-addition of isoxazolinones afforded a series of enantioenriched N-diarylmethane substituted isoxazolinones with high yields and enantioselectivities (up to 97 : 3 er). This reaction not only provides a useful approach for intermolecular chiral C-N bond formation but also demonstrates the immense potential of isoxazol-5-ones as N-nucleophiles in catalytic asymmetric reactions.

3.
World J Gastroenterol ; 25(45): 6607-6618, 2019 Dec 07.
Article in English | MEDLINE | ID: mdl-31832001

ABSTRACT

BACKGROUND: It is well known that nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR). LB100, a serine/threonine protein phosphatase 2A (PP2A) inhibitor, is closely related to IR. However, there is little data regarding its direct influence on NAFLD. AIM: To elucidate the effect and underlying mechanism of LB100 in NAFLD. METHODS: After 10 wk of high fat diet (HFD) feeding, male C57BL/6 mice were injected intraperitoneally with vehicle or LB100 for an additional 6 wk (three times a week). The L02 cell line was treated with LB100 and free fatty acids (FFAs) for 24 h. Hematoxylin and eosin and oil red O staining were performed for histological examination. Western blot analysis was used to detect the protein expression of Sirtuin 1 (Sirt1), total and phosphorylated AMP-activated protein kinase α (AMPKα), and the proteins involved in lipogenesis and fatty acid oxidation. The mRNA levels were determined by qPCR. Pharmacological inhibition of AMPK was performed to further examine the exact mechanism of LB100 in NAFLD. RESULTS: LB100 significantly ameliorated HFD-induced obesity, hepatic lipid accumulation and hepatic injury in mice. In addition, LB100 significantly downregulated the protein levels of acetyl-CoA carboxylase, sterol regulatory element-binding protein 1 and its lipogenesis target genes, including stearoyl-CoA desaturase-1 and fatty acid synthase, and upregulated the levels of proteins involved in fatty acid ß-oxidation, such as peroxisome proliferator-activated receptor α (PPARα), peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α), carnitine palmitoyltransferase 1α, acyl-CoA oxidase 1 and uncoupling protein 2, as well as the upstream mediators Sirt1 and AMPKα in the livers of HFD-fed mice. In vitro, LB100 alleviated FFA-induced lipid accumulation in L02 cells through the AMPK/Sirt1 signaling pathway. Further studies showed that the curative effect of LB100 on lipid accumulation was abolished by inhibiting AMPKα in L02 cells. CONCLUSION: PP2A inhibition by LB100 significantly ameliorates hepatic steatosis by regulating hepatic lipogenesis and fatty acid oxidation via the AMPK/Sirt1 pathway. LB100 may be a potential therapeutic agent for NAFLD.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Enzyme Inhibitors/pharmacology , Non-alcoholic Fatty Liver Disease/drug therapy , Piperazines/pharmacology , Protein Phosphatase 2/antagonists & inhibitors , Sirtuin 1/metabolism , Acyl-CoA Oxidase/metabolism , Animals , Carnitine O-Palmitoyltransferase/metabolism , Diet, High-Fat , Disease Models, Animal , Fatty Acids/metabolism , Gene Expression Regulation , Lipid Metabolism , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , Non-alcoholic Fatty Liver Disease/enzymology , Oxygen/metabolism , PPAR alpha/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism , Piperazines/therapeutic use , Signal Transduction , Uncoupling Protein 2/metabolism
4.
Guang Pu Xue Yu Guang Pu Fen Xi ; 30(8): 2205-10, 2010 Aug.
Article in Chinese | MEDLINE | ID: mdl-20939340

ABSTRACT

To validate the HJ-1A HSI red edge indices, spectral reflectance data from EO-1 Hyperion of close date were used to simulate the band reflectance of HJ-1A HSI. Four red edge indices (red vale position, red edge position, red edge slop and red edge swing) were extracted from both simulated and actual HJ-1A HSI band reflectance. Comparisons of the 4 red edge indices between simulated and actual HJ-1A HSI were made to validate the red edge indices product of HJ-1A HSI. The average correlation coefficient of red edge reflectance between actual and simulated HJ-1A HSI is 0.946 and its standard deviation is 0.011, thus a high consistency could be found. The correlation coefficients of red edge indices between simulated and actual HJ-1A HSI were 0.414, 0.543, 0.808 and 0.802 for red edge position, red vale position, the red edge swing and red edge slop respectively. An obvious regular varying trend was found for these 4 red edge indices along different vegetation cover fraction. The standard deviations of differential images between real and simulated HJ-1A HSI red edge indices are 5.75, 1.86, 5.7 e(-4) and 0.024. The result showed that the red edge indices from HJ-1A HSI is consistent with that from simulated indices from Hyperion; the vegetation variation could be effectively reflected in HJ-1A HSI red edge indices.

SELECTION OF CITATIONS
SEARCH DETAIL
...